pobilukast has been researched along with sb 201146 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haswell, M; Hill, A; Jackson, N; Jackson, S; Kilfeather, S; Lee, E; Lindo, T; Meng-Choong, L; Reynolds, P | 1 |
Kilfeather, S; Lee, E; Robertson, T; Smith, J | 1 |
2 other study(ies) available for pobilukast and sb 201146
Article | Year |
---|---|
Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Topics: 5-Lipoxygenase-Activating Proteins; Acrylates; Adult; Apoptosis; Arachidonate 5-Lipoxygenase; Benzeneacetamides; Carrier Proteins; Cell Survival; Dexamethasone; Dicarboxylic Acids; Dose-Response Relationship, Drug; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxamic Acids; In Vitro Techniques; Indoles; Leukotriene Antagonists; Leukotriene B4; Lipopolysaccharides; Lipoxygenase Inhibitors; Lung Diseases, Obstructive; Membrane Proteins; Neutrophils; Pyridines; Receptors, Leukotriene B4 | 1999 |
Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals.
Topics: Acrylates; Adult; Aged; Apoptosis; Asthma; Benzeneacetamides; Bronchial Hyperreactivity; Cell Survival; Culture Media, Conditioned; Dicarboxylic Acids; Eosinophils; Female; Fibronectins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxamic Acids; Indoles; Leukotriene Antagonists; Leukotrienes; Lymphocytes; Male; Mast Cells; Middle Aged; Pyridines; Respiratory Hypersensitivity | 2000 |